| Literature DB >> 30320144 |
Jeffrey Jancuska1, John Matthews1, Tyler Miller1, Melissa A Kluczynski1, Leslie J Bisson1.
Abstract
BACKGROUND: The number of systematic reviews and meta-analyses published on the rotator cuff (RC) has increased markedly.Entities:
Keywords: meta-analysis; repair; rotator cuff; systematic review
Year: 2018 PMID: 30320144 PMCID: PMC6154263 DOI: 10.1177/2325967118797891
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart. RC, rotator cuff.
Number of Articles by Rotator Cuff Topic
| Topic of Systematic Review | Articles Found, n |
|---|---|
| Anatomy and function | 5 |
| Histology and genetics | 4 |
| Diagnosis | 19 |
| Epidemiology | 8 |
| Rotator cuff tears in athletes | 5 |
| Nonoperative vs operative treatment | 14 |
| Surgical repair methods | 43 |
| Concomitant conditions and surgical procedures | 9 |
| Rotator cuff tears after total shoulder arthroplasty | 2 |
| Biological augmentation | 29 |
| Postoperative rehabilitation | 21 |
| Outcomes assessment | 37 |
| Patient-reported outcome measures and their psychometric properties | 6 |
| Cost-effectiveness of rotator cuff repair | 1 |
| Quality of randomized controlled trials | 2 |
Topics are not mutually exclusive.
Changes to the Extracellular Matrix Components and Enzymes in Rotator Cuff Disease
| Matrix Components | Matrix Enzymes |
|---|---|
| Type I collagen ↑[ | MMP-1 ↑[ |
| Other Enzymes | |
| COX-1 ↑[ | |
| Transcription Factors | |
| SOX9 ↑[ |
Includes changes to other enzymes and transcription factors. ↑, increased; ↓, decreased. Used with permission from Dean et al.[38] ADAM, a disintegrin and metalloproteinases; COX, cyclooxygenase; FOX, forkhead box protein; ftRCT, full-thickness rotator cuff tear; GAG, glycosaminoglycan; MMP, matrix metalloproteinase; NOS, nitric oxide synthase; ptRCT, partial-thickness rotator cuff tear; RCT, rotator cuff tear; SOX9, sex-determining region Y-box 9 protein; TIMP, tissue inhibitor of metalloproteinase.
Changes to Cytokines, Growth Factors, Neuronal Factors, Apoptosis/Cell Cycle–Related Factors, and Other Factors in Rotator Cuff Disease
| Cytokines/Growth Factors | Apoptosis/Cell Cycle Related |
|---|---|
| IL-1α ↑[ | HIF-1α ↑[ |
| Neuronal Factors | Others |
| Substance P ↑[ | Ubiquitin proteasome pathway UBE2A and UBE3A ↑ (massive
tears vs small/controls[ |
↑, increased; ↓, decreased. Used with permission from Dean et al.[38] AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ADP, adenosine diphosphate; BCL, B-cell lymphoma; BMP, bone morphogenetic protein; cFLIP, cellular FLICE (FADD-like IL-1beta-converting enzyme)-inhibitory protein; CTSB, cathepsin B; FGF, fibroblast growth factor; GABA, gamma-aminobutyric acid; GAP43, growth-associated protein 43; HIF, hypoxia-inducible factor; IGF, insulin-like growth factor; IL, interleukin; NF-KB, nuclear factor kappa light chain enhancer of activated B cells; NGF, nerve growth factor; PGP9.5, protein gene product 9.5; RCT, rotator cuff tear; TGF, transforming growth factor; TNF, tumor necrosis factor; UBE, ubiquitin conjugating enzyme; VEGF, vascular endothelial growth factor; vWF, Von Willebrand factor.
Prevalence of Rotator Cuff Abnormalities Overall and Among Asymptomatic and Symptomatic Patients, in the General Population, and After Shoulder Dislocation
| Age in Decades, y | ||||||||
|---|---|---|---|---|---|---|---|---|
| <20 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | >80 | |
| Overall | ||||||||
| Shoulders, n | 299 | 434 | 481 | 933 | 1531 | 1134 | 1032 | 268 |
| Prevalence cuff abnormality, % (n) | 9.7 (29) | 6.9 (30) | 13 (60) | 13 (117) | 19 (285) | 30 (338) | 41 (427) | 62 (166) |
|
|
| |||||||
| Odds ratio (95% CI) | Reference value | 0.69 (0.41-1.2) | 1.3 (0.83-2.1) | 1.3 (0.87-2.1) | 2.1 (1.4-3.2) | 4.0 (2.6-5.9) | 6.6 (4.4-9.8) | 15 (9.6-24) |
|
| .18 | .24 | .19 |
|
|
|
| |
| Asymptomatic | ||||||||
| Shoulders, n | 0 | 75 | 70 | 470 | 807 | 495 | 468 | 59 |
| Prevalence cuff abnormality, % (n) | 6.7 (5) | 21 (15) | 4 (18) | 9.5 (77) | 16 (77) | 28 (130) | 56 (33) | |
|
|
| |||||||
| Odds ratio (95% CI) | — | Reference value | 3.8 (1.3-11) | 0.56 (0.20-1.5) | 1.5 (0.58-3.8) | 2.6 (1.0-6.6) | 5.4 (2.1-14) | 18 (6.3-50) |
|
| .014 | .26 | .42 |
|
|
| ||
| General population | ||||||||
| Shoulders, n | 2 | 12 | 140 | 254 | 473 | 442 | 394 | 164 |
| Prevalence cuff abnormality, % (n) | 0 | 0 | 2.9 (4) | 7.9 (20) | 14 (67) | 31 (138) | 50 (196) | 65 (106) |
|
|
| |||||||
| Odds ratio (95% CI) | — | — | Reference value | 2.9 (0.97-8.7) | 5.6 (2.0-16) | 15 (5.6-43) | 34 (12-93) | 62 (22-177) |
|
| .056 |
|
|
|
| |||
| Symptomatic | ||||||||
| Shoulders, n | 264 | 193 | 212 | 123 | 163 | 120 | 109 | 8 |
| Prevalence cuff abnormality, % (n) | 9.9 (26) | 4 (8) | 14 (29) | 40 (50) | 61 (163) | 68 (81) | 63 (69) | 50 (4) |
|
|
| |||||||
| Odds ratio (95% CI) | Reference value | 0.40 (0.18-0.89) | 1.5 (0.83-2.55) | 6.2 (3.6-11) | 15 (8.7-24) | 19 (11-33) | 16 (9.0-28) | 9.2 (2.2-39) |
|
| .20 |
|
|
|
|
| ||
| Dislocations | ||||||||
| Shoulders, n | 33 | 154 | 59 | 85 | 88 | 77 | 61 | 37 |
| Prevalence cuff abnormality, % (n) | 9 (3) | 11 (17) | 20 (12) | 34 (29) | 47 (41) | 55 (42) | 53 (32) | 62 (23) |
|
|
| |||||||
| Odds ratio (95% CI) | Reference value | 1.2 (0.34-4.5) | 2.6 (0.66-9.8) | 5.2 (1.5-18) | 8.7 (2.5-31) | 12 (3.4-43) | 11 (3.0-40) | 16 (4.2-64) |
|
| .74 | .17 | .011 |
|
|
|
| |
Italic text indicates statistically significant difference. Used with permission from Teunis et al.[226]
Overall sums asymptomatic, general population, symptomatic, and dislocations.
General population includes cadavers.
Figure 2.Flowchart of predictors. Pre-op, preoperative; WCB, Workers’ Compensation Board. Used with permission from Raman et al.[175]
Quality of Measurement Properties per Questionnaire: Summary
| Internal Consistency | Reliability | Measurement Error | Content Validity | Structural Validity | Hypothesis Testing | Criterion Validity | Responsiveness | |
|---|---|---|---|---|---|---|---|---|
| ASES | – | ++ | – | ? | ? | – – | ? | ? |
| Constant | ? | ++ | ? | NA | NA | – – | ? | + |
| DASH | ? | ++ | – – | NA | ++ | + | NA | ++ |
| KSS | ? | NA | NA | ? | NA | ? | ? | ? |
| L’Insalata | ? | ? | NA | ? | NA | ? | ? | ? |
| OSS | ? | – | NA | ? | NA | + | NA | ? |
| Penn | ? | + | ? | ? | NA | ? | NA | ? |
| RC-QOL | ? | ? | NA | ? | NA | – | NA | ? |
| SAL | NA | + | NA | NA | NA | ? | NA | NA |
| SDQ | ? | ? | NA | NA | NA | – | NA | ? |
| SPADI | +++ | ++ | – – | NA | +++ | –/+ | ? | + |
| SST | +++ | ++ | – | ? | NA | +/+ | ? | + |
| SSV | NA | NA | NA | NA | NA | – | NA | NA |
| UCLA | ? | + | ? | NA | NA | + | ? | ? |
| WOOS | NA | + | NA | NA | NA | ? | NA | ? |
| WORC | ++ | ++ | ? | +++ | NA | ++ | NA | + |
A plus sign (+) indicates positive evidence; a question mark (?), indeterminate evidence; and a negative sign (–), negative evidence. Used with permission from Huang et al.[76] ASES, American Shoulder and Elbow Surgeons shoulder outcome score; Constant, Constant-Murley score; DASH, Disabilities of the Arm, Shoulder and Hand score; KSS, Korean Shoulder Scoring System; L’Insalata, L’Insalata Shoulder Rating Questionnaire; NA, no information available; OSS, Oxford Shoulder Score; Penn, Penn Shoulder Score; RC-QOL, Quality-of-Life Outcome Measure for Rotator Cuff Disease; SAL, Shoulder Activity Level; SDQ, Shoulder Disability Questionnaire; SPADI, Shoulder Pain and Disability Index; SST, Simple Shoulder Test score; SSV, Subjective Shoulder Value; UCLA, University of California, Los Angeles shoulder score; WOOS, Western Ontario Osteoarthritis Shoulder index; WORC, Western Ontario Rotator Cuff Index.